Melanoma associated with rituximab: A RADAR (Research on Adverse Drug events And Reports) project - 09/05/15
Beatrice Nardone, MD, PhD, Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States; Finola M. Bruins, Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States; Doriana Massimino, MD, private practice, Bologna, Italy; Rasha Arabyat, MPH, College of Pharmacy, University of New Mexico, Albuquerque, NM, United States; Dennis W. Raisch, PhD, College of Pharmacy, University of New Mexico, Albuquerque, NM, United States; Dennis P. West, PhD, Department of Dermatology and Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, United States
Le texte complet de cet article est disponible en PDF. Commercial support: None identified. |
Vol 72 - N° 5S1
P. AB209 - mai 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?